Regulation of blood coagulation by the protein C system
- PMID: 1317308
- DOI: 10.1096/fasebj.6.8.1317308
Regulation of blood coagulation by the protein C system
Abstract
Protein C is a plasma, vitamin K-dependent zymogen of a serine protease that can inhibit blood coagulation. Protein C is regulated by a series of reactions known as the protein C pathway. The importance of this pathway is seen in the occurrence of thrombosis in individuals with deficiencies in elements of the pathway like protein C and protein S. Work on several steps in this pathway has revealed that mechanisms involved in activation of protein C and the expression of its anticoagulant activity have features that allow for the expression of the anticoagulant activity away from sites in which procoagulant reactions occur, but not systemically. Thrombin, the principal procoagulant enzyme at the site of an injury, is converted to an anticoagulant enzyme at distant sites through its interaction with the endothelial cell protein thrombomodulin. Structural and functional studies have revealed the importance of several domain structures in the modulation of thrombin activity. Structural features of both activated protein C and its substrates (coagulation factors V and VIII) are such that they require the localization of enzyme and substrate on the surface of phosphatidyl serine containing membranes for optimum activity.
Similar articles
-
The role of complex formation and epidermal growth factor-like domains in the regulation of blood coagulation by the thrombomodulin-protein C system.Nihon Ketsueki Gakkai Zasshi. 1989 Dec;52(8):1343-9. Nihon Ketsueki Gakkai Zasshi. 1989. PMID: 2560886 Review.
-
Protein C.Prog Hemost Thromb. 1984;7:25-54. Prog Hemost Thromb. 1984. PMID: 6099583 Review.
-
Progress in the understanding of the protein C anticoagulant pathway.Int J Hematol. 2004 Feb;79(2):109-16. doi: 10.1532/ijh97.03149. Int J Hematol. 2004. PMID: 15005336 Review.
-
[Molecular biology of protein C-thrombomodulin pathway. Structure and function, and basic studies on its clinical application].Nihon Rinsho. 1993 Jun;51(6):1610-9. Nihon Rinsho. 1993. PMID: 8391599 Review. Japanese.
-
Thrombomodulin, an endothelial anticoagulant; its structure, function and expression.Jpn Circ J. 1992 Feb;56(2):187-91. doi: 10.1253/jcj.56.187. Jpn Circ J. 1992. PMID: 1312651 Review.
Cited by
-
The Association between Coagulation and Atrial Fibrillation.Biomedicines. 2024 Jan 25;12(2):274. doi: 10.3390/biomedicines12020274. Biomedicines. 2024. PMID: 38397876 Free PMC article. Review.
-
Activated protein C inhibits mesothelial-to-mesenchymal transition in experimental peritoneal fibrosis.J Thromb Haemost. 2023 Jan;21(1):133-144. doi: 10.1016/j.jtha.2022.10.012. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36695376 Free PMC article.
-
High levels of factor VIII activity in patients with acquired hemophilia A in remission are associated with unusually low coagulation potentials.Int J Hematol. 2023 May;117(5):669-677. doi: 10.1007/s12185-022-03528-0. Epub 2023 Jan 6. Int J Hematol. 2023. PMID: 36607560
-
Personalized modulation of coagulation factors using a thrombin dynamics model to treat trauma-induced coagulopathy.NPJ Syst Biol Appl. 2021 Dec 7;7(1):44. doi: 10.1038/s41540-021-00202-9. NPJ Syst Biol Appl. 2021. PMID: 34876597 Free PMC article.
-
Cancer-Associated Thrombosis: A New Light on an Old Story.Diseases. 2021 May 4;9(2):34. doi: 10.3390/diseases9020034. Diseases. 2021. PMID: 34064390 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
